The European Medicines Agency (EMEA) advises sponsors of epileptic disorder treatments in Phase III trials to use certain primary endpoints and include an adequate number of geriatric patients.
Serum MMP-9、peripheral leucocytes、and blood lipid of geriatric patients with acute cerebral infarction
Larger trials are needed to definitively establish whether oral iron-replacement therapy is efficacious for correcting postoperative anemia in geriatric patients with a hip fracture.
